Lisocabtagene Maraleucel (Breyanzi) FDA Approval: 10 Stats Lymphoma 17 Mins Read0 Lisocabtagene Maraleucel has been approved by the FDA for the second-line treatment of large B cell lymphoma LBCL Lisocabtagene Maraleucel…
